Commentary

/Commentary

Apollo Shrugged – Can Technology Improve Patient Adherence?

By | April 4th, 2016|Apollo Shrugged, Blog, Commentary|

  Can Technology Improve Patient Adherence? In my last blog, [...]

Bloom Burton’s analyst David Martin speaks to BNN about Concordia’s latest earnings

By | March 31st, 2016|Bloom Burton, Commentary, News|

Click on the image to view the full video.

Guest Editorial- Keeping your business investor friendly

By | February 25th, 2016|Blog, Commentary, Guest Editorial|

If someone asks you how your business is doing, you [...]

Apollo shrugged – On being unintentionally non-adherent

By | January 18th, 2016|Apollo Shrugged, Blog, Commentary|

On being unintentionally non-adherent I wonder how many of us [...]

Q3 2015 Share Price Performance (Part 2)

By | November 30th, 2015|Analysis, Capital Markets, Commentary|

Tier 2 companies lost all previous 2015 gains in Q3 [...]

Guest Editorial

By | November 22nd, 2015|Blog, Commentary, Guest Editorial|

Canada continues to be one of the world’s leaders in [...]

Bloom Burton’s analyst David Martin speaks to BNN about Concordia’s sell-off and the future of biotech in Canada

By | November 13th, 2015|Bloom Burton, Commentary, News|

Click on the image to view the full video.  

Cross-Border Mergers and Acquisitions – 5 Tips for a Successful Deal

By | August 31st, 2015|Blog, Commentary, Guest Editorial|

As the world becomes one giant global marketplace, it is [...]

Canada in Science – August 28, 2015

By | August 28th, 2015|Blog, Canada in Science, Commentary|

Welcome to your Canada in Science Review for August 28th, [...]

Canada in Science – August 14, 2015

By | August 14th, 2015|Blog, Canada in Science, Commentary|

Welcome to your Canada in Science Review for August 14th, 2015! [...]